Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Clinical trial NCT05549297 · RECRUITING

Trial details

NCT number: NCT05549297
Sponsor: Immunocore Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Melanoma

Start date: 2022-12-19
Primary completion: 2028-03-01
Enrollment: 540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.